Antisoma Venture Capital Fund
Venture Capital Family Office Est. 2005
Also known as Bioscience Equity Partners Pty Ltd.
USD 800M
Estimated FUM
- Type
- Venture Capital
- Founded
- 2005
- Focus
- Generalist Tech
About
We are a European family office owned fund; we understand biosciences and medical technologies better than anyone else in the Private Equity and Venture Capital ecosystem. The capital of this fund has been generated by the family office's active bioscience investments across Europe, USA, and the APAC region since 1995. We understand the intricacies of commercializing bioscience discoveries. We also acknowledge that bioscience venture leadership requires deep courage-from founders and the investors that back them.
Investment Focus
Investment size
USD 25M - USD 100M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Focus Areas
Stages
Growth Public / Listed Series A Series B
Domains
Healthcare Technology
Focus
Generalist Tech
Investment Geographies
Primary Markets
Australia United States
Coverage
Global Regions
Oceania North America
Coverage is a guide only.
Location
Headquarters
Unknown
Office Presence
2 countries
Australia United States
2 known offices
Sydney, NSW, Australia
New York, United States
People also viewed
Goldman Sachs
The Merchant Banking Division (MBD) is the investing and lending division of Goldman Sachs, and is one of the largest asset managers in the world. The capital of MBD is a mixture of Goldman's balance sheet plus external capital it has raised through a series of funds. MBD invests globally across almost all asset classes, including senior debt, mezzanine debt, late stage venture capital and growth equity, control private equity, infrastructure and real estate. Note that in certain markets, including in Australia and China, the Merchant Banking Division is known as the Principal Investment Area (PIA).
Prior to August 2019, when all of the investing divisions of Goldman Sachs merged, Goldman Sachs had a separate investing and lending division known as the Special Situations Group (SSG). SSG focused on investing the firm's balance sheet in a wide variety of asset classes. It had no external capital. SSG was formed during the Asian Financial Crisis, and originally specialised in distressed lending and acquisition of distressed assets. However, SSG quickly expanded into a broader special situations investor, focusing on areas where other forms of capital were not flowing efficiently, or where returns are out sized versus in-house perceptions of risk.
Andreessen Horowitz
Andreessen Horowitz backs bold entrepreneurs who move fast, think big, and are committed to building the next major franchises in technology. Founded by Marc Andreessen and Ben Horowitz, the firm provides entrepreneurs with access to expertise and insights in innovation, executive and technical talent, market intelligence, policy and regulatory affairs, business development, and marketing and brand-building.
Blackbird Ventures
Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.
New Enterprise Associates
New Enterprise Associates (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With over $19 billion in cumulative committed capital since the firm's founding in 1977, NEA invests in technology and healthcare companies at all stages in a company's lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.
Accel-KKR
Accel-KKR is a leading mid-market software and technology investor, established in 2000 as a joint venture between leading venture investor Accel Partners and leading private equity firm KKR. Accel-KKR brings capital, expertise and a network of relationships to our portfolio companies, enabling them to grow faster and more profitably. Throughout the years, the firm has taken a collaborative approach to working with our management teams so that, together, we can help our companies reach their full potential. Accel-KKR focuses primarily on three types of transactions: buyouts of divisions, subsidiaries and business units from public companies; acquisitions and recapitalizations of closely-held private companies; and going-private transactions of small public companies.
Grok Ventures
Grok Ventures is the private investing vehicle of Mike Cannon-Brookes, co-founder of Atlassian and one of Australia's most successful technology entrepreneurs. Grok Ventures invests in fast-growing technology-enabled businesses with world-class management teams who are solving big problems. Grok particularly likes food and energy companies. We have private, patient, long-term capital, with the flexibility to participate from early-stage or seed financing through to late stage funding rounds (although we prefer to be involved earlier).